Jazz Pharmaceuticals plc Other Non-Current Assets
Jazz Pharmaceuticals plc (JAZZ) had Other Non-Current Assets of $86.30 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-03
- 2026-06-30: Other Assets, Noncurrent $86.30M.
- 2026-03-31: Other Assets, Noncurrent $94.70M.
- 2025-12-31: Other Assets, Noncurrent $99.00M; Other Assets, Noncurrent as first filed $99.03M.
- 2025-09-30: Other Assets, Noncurrent $103.07M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $86.30M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $94.70M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $99.00M 10-Q · filed 2026-08-03 | $99.03M 10-K · filed 2026-02-24 |
| 2025-09-30 | $103.07M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $121.27M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $116.52M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $114.48M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $75.23M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $71.42M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $70.78M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $67.46M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $76.08M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $65.98M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $64.08M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $55.14M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $35.15M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $34.61M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $35.51M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $40.81M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $45.78M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $47.08M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $30.35M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $25.72M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $38.65M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $48.83M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $47.11M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $47.91M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $44.27M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $40.84M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $40.74M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $42.70M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $56.00M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $23.40M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $22.98M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $16.42M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $16.42M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $16.64M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $17.63M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $14.06M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $37.76M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $37.01M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $29.54M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $9.27M 10-K · filed 2017-02-28 | $27.55M 10-K · filed 2016-02-23 |
| 2015-09-30 | $25.39M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $22.50M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $19.19M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $15.93M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $13.48M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $11.13M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $9.30M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $7.30M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $6.39M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $5.50M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $4.55M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $3.66M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $20.41M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $19.23M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $385.00K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $87.00K 10-K · filed 2013-02-26 | |
| 2011-09-30 | $83.00K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $152.00K 10-Q · filed 2011-08-03 | |
| 2010-12-31 | $335.00K 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |